The transformative impact of LSG and SR‐LRYGB surgeries on metabolic health goes beyond weight loss, heralding rapid and sustained improvements in glucose homeostasis, insulin sensitivity, and T2D remission [17, 18]. This evidence concerns the gene INS and type 2 diabetes mellitus.